Mycoplasma pneumonia cases have dramatically increased, linked to less mask usage. An antibiotic shortage is worsening the challenge of managing...
COVID-19 spread worldwide because of the secrecy of China. Don't let that happen again as new pathogens are causing the fresh wave of respiratory infections.
Japan begins increasing individual contributions to the cost of COVID-19 treatment. Is 10% enough? The search is on for a fair balance.
After nearly 7 million deaths, Tedros has declared the crisis is over. But WHO's deference to China and the origins of COVID-19 have yet to be...
We still encounter individuals daily who are elderly, have health concerns, or live with family members who are at high risk of serious illness.
There is a shocking contrast between the COVID-19 case numbers and deaths announced by Beijing compared to local regions in China.
Relying on Xocova alone is not enough. It should be used with other available drugs according to their characteristics to suppress a resurgence of COVID-19.
Shionogi's Xocova is Japan's first domestically produced COVID drug to gain approval for practical use as preparation gear up for the "eighth wave."
COVID-19 is a fast-mutating virus. Japan is rolling out the new omicron booster shot, but the virus might still be faster.
Is tourism travel possible? Do you need a PCR test, or a vaccine certificate to enter the country? Here are the necessary information starting September 7.
Japan’s medical system is starting to feel the impact after several weeks of record-high COVID cases since the last week of July.
Temporary testing facilities at major train stations and airports should be the first order of defense this summer.
